insights_auto
Hvorfor har AZN gått opp? 3,76%?
Gå mer i dybdenchevron_right
AZN:LON
AstraZeneca
12 762,00 GBX
arrow_upward
+3,76%(+462,00) 1 D
15. okt., 15:07:10 GMT+1 · GBX
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for AZN …
Åpne
12 396,00 GBX
Høy
12 806,00 GBX
Lav
12 334,00 GBX
Markedsverdi
265,20 mrd.
Snittvolum
2,78 mill.
Volum
1,29 mill.
Utbytte
1,87 %
Kvartalsvis utbytte
59,75 GBX
Første dato etter utbytte
6. aug. 2026
P/E-forhold
25,28
52 u høy
15 732,00 GBX
52 u lav
9 892,00 GBX
EPS
5,05 GBX
Utestående aksjer
1,55 mrd.
Antall ansatte
96k
Åpne
12 396,00 GBX
Høy
12 806,00 GBX
Lav
12 334,00 GBX
Markedsverdi
265,20 mrd.
Snittvolum
2,78 mill.
Volum
1,29 mill.
Utbytte
1,87 %
Kvartalsvis utbytte
59,75 GBX
Første dato etter utbytte
6. aug. 2026
P/E-forhold
25,28
52 u høy
15 732,00 GBX
52 u lav
9 892,00 GBX
EPS
5,05 GBX
Utestående aksjer
1,55 mrd.
Antall ansatte
96k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Yahoo Finance
·
for 2 timer siden
The Zacks Analyst Blog Highlights Mastercard, AstraZeneca and Sandisk
Seeking Alpha
·
for 3 timer siden
AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro
Reuters
·
for 3 timer siden
AstraZeneca strikes $40 million AI drug discovery deal with insitro
ad-hoc-news.de
·
for 6 timer siden
AstraZeneca reports HICKORY results for AstraZeneca stock
Profil
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Om AstraZeneca
Administrerende direktørPascal Soriot
Ansatte96,1k
Grunnlagt6. apr. 1999
HovedkontorCambridge, Cambridgeshire, Storbritannia
Sektor-
Nettstedastrazeneca.com